Carrera Capital Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Carrera Capital Advisors's ABUS Position: Q3 2026 in Review
Carrera Capital Advisors increased its Arbutus Biopharma (ABUS) stake by 126% in Q3 2026, buying an estimated $1.57M and bringing the position to 582,144 shares worth $2.78M. The position accounts for 0.39% of the portfolio, ranked #56.
Carrera Capital Advisors first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Carrera Capital Advisors held 582,144 shares of Arbutus Biopharma worth $2.78M as of Q3 2026.
- Carrera Capital Advisors bought 324,977 Arbutus Biopharma shares in Q3 2026, an estimated $1.57M.
- Arbutus Biopharma made up 0.39% of Carrera Capital Advisors's portfolio in Q3 2026, its #56 holding.
- Carrera Capital Advisors first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
- 214 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Carrera Capital Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.